Company Filing History:
Years Active: 2016-2018
Title: Heiko Degendorfer: Innovator in Pharmaceutical Composition
Introduction
Heiko Degendorfer is a notable inventor based in Kundl, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. With a total of 2 patents to his name, Degendorfer's work has the potential to impact medical treatments significantly.
Latest Patents
Degendorfer's latest patents include a "Penicillin retard composition for intramuscular injection." This invention focuses on an injection syringe that contains an injectable composition comprising penicillin, a salt or prodrug thereof, along with one or more pharmaceutically acceptable excipients and water. Notably, this composition is free of any preservative agents. Additionally, he has developed a "Pharmaceutical composition containing crystalline sorafenib tosylate," which pertains to an oral solid dosage form, specifically a tablet that includes sorafenib tosylate polymorphic form III.
Career Highlights
Heiko Degendorfer is associated with Sandoz AG, a leading global pharmaceutical company. His work at Sandoz has allowed him to focus on innovative drug delivery systems and formulations that enhance patient care and treatment efficacy.
Collaborations
Throughout his career, Degendorfer has collaborated with esteemed colleagues, including Johannes Raneburger and Christoph Bitter. These collaborations have fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.
Conclusion
Heiko Degendorfer's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through effective drug formulations. His patents reflect a dedication to advancing medical science and enhancing patient outcomes.